Connor, Clark & Lunn Investment Management Ltd.

Position in SIGA — Siga Technologies Inc

CIK 1596800 VANCOUVER, A1

Back to SIGA Full portfolio

Position in SIGA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$253,737

+$60,795 QoQ

Shares Held

69,708

+93.3% QoQ

Ownership

0.097%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#56

of 160 holders

Holding Since

Jun 2022

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in SIGA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $83,482,045 across 14 Drug Manufacturers - Specialty & Generic names. SIGA ranks #13 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KNSA	Kiniksa Pharmaceuticals International, plc	572,598	$36,617,642
2	AMLX	Amylyx Pharmaceuticals, Inc.	721,002	$12,949,195
3	ZTS	Zoetis Inc.	118,491	$8,514,763
4	IRWD	Ironwood Pharmaceuticals Inc	1,811,714	$7,627,315
5	TEVA	Teva Pharmaceutical Industries Ltd	192,766	$6,530,911
6	RDY	Dr Reddys Laboratories Ltd	231,979	$3,361,375
7	EBS	Emergent BioSolutions Inc.	353,983	$2,966,377
8	ELAN	Elanco Animal Health Inc	95,381	$2,347,326

All Filings in SIGA

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$253,737	69,708	+93.3%	Shares	Sole	2026-08-13
2026-03-31	$192,942	36,064	-32.4%	Shares	Sole	2026-05-11
2024-06-30	$405,070	53,369	-56.8%	Shares	Sole	2024-08-09
2024-03-31	$1,056,740	123,451	+1031.6%	Shares	Sole	2024-05-09
2023-06-30	$55,090	10,909	-96.2%	Shares	Sole	2023-08-10
2022-09-30	$2,975,494	288,883	-0.0%	Shares	Sole	2022-11-10
2022-06-30	$3,346,376	288,979	—	Shares	Sole	2022-08-05
No filing history on record for this holder in this stock.